Related Experiment Video
Updated: Oct 7, 2025
07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
622
Response to PD-1 Immunotherapy in Metastatic Spiradenocarcinoma
Clinton Wu1, Melissa Chow1, Michelle Temby1
1Departments of Melanoma Oncology, University of California, San Francisco, San Francisco, CA.
JCO Precision Oncology
|January 7, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
01:27Tumor Immunotherapy
719
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
719
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K